How to Source Fitusiran for Pharmaceutical Formulation

Fitusiran (injection (prefilled syringe), 50 mg/0.5 ml, 20 mg/0.2ml) is classified under Critical Care. It is therapeutically aligned with reference brands such as Generic formulations marketed under different names. This guide highlights key sourcing factors buyers should consider when procuring high-quality Fitusiran for formulation, R&D, or bulk manufacturing.

Product Overview: Fitusiran is a synthetic small interfering RNA (siRNA)–based therapeutic developed for prophyl...

1. Regulatory Compliance & Documentation

Ensure suppliers provide:

• ✔ Valid DMF (Drug Master File)
• ✔ COA (Certificate of Analysis) for each batch
• ✔ GMP, ISO, or ICH Q7 compliance certificates

2. Purity, Grade & Specification Matching

Fitusiran must meet exact grade and purity for your dosage form:

• ✔ USP / EP / JP grade verification
• ✔ Particle size distribution check
• ✔ Residual solvent and heavy metal limits

3. Supplier Reliability & Audit History

• ✔ Positive past audit reports
• ✔ Pharma client references
• ✔ Years of proven API manufacturing experience

4. Commercial Terms: Pricing, MOQ & Flexibility

• ✔ Transparent pricing
• ✔ Pilot batch MOQ flexibility
• ✔ Volume-based discounts

5. Lead Time, Inventory & Logistics

Typical lead time for Fitusiran is 4–6 weeks.

• ✔ Emergency dispatch options
• ✔ Regional warehousing
• ✔ Special storage if needed

6. Formulation Support

• ✔ Technical datasheets
• ✔ Sample availability
• ✔ Stability study support

Conclusion

Sourcing Fitusiran is more than procurement—it’s a strategic partnership. With its injection (prefilled syringe) form and 50 mg/0.5 ml, 20 mg/0.2ml specification, choosing a compliant supplier ensures consistent quality and regulatory approval. Prioritize documentation, verify compatibility, and build relationships with transparent, reliable suppliers to secure long-term success.

Frequently Asked Questions For Sourcing of Fitusiran